Prostate cancer: open trials in Czechia

• NCT06136624

  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Masarykuv Onkologicky Ustav, Brno-Stred · University Hospital Olomouc, Olomouc · Fakultni Nemocnice Ostrava, Poruba · Fakultni Nemocnice Motol a Homolka, Prague

  Registry updated 2026-11-05

• NCT07253987

  Cancer Survivors Program

  Trial Treatment · Masaryk Memorial Cancer Institute

  Masaryk Memorial Cancer Institute, Brno

  Registry updated 2026-11-03

• NCT06629779

  A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

  Trial Treatment · Phase 3 · Pfizer

  Krajska nemocnice Liberec a.s., Liberec I-Stare Mesto · University Hospital Olomouc, Olomouc · Fakultni nemocnice Ostrava, Ostrava · Multiscan s.r.o., Pardubice · Fakultni nemocnice Kralovske Vinohrady, Prague · Urocentrum Praha s.r.o., Prague · Fakultni Thomayerova nemocnice, Prague 4

  Registry updated 2026-10-30

• NCT06925737

  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Masarykuv Onkologicky Ustav, Brno-Stred · University Hospital Olomouc, Olomouc · Fakultni nemocnice Ostrava, Ostrava · Fakultni Nemocnice Motol a Homolka, Prague

  Registry updated 2026-10-30

• NCT07288359

  Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Olomouc

  Registry updated 2026-10-29

• NCT04557449

  Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

  Trial Treatment · Phase 1/2 · Pfizer

  University Hospital Olomouc, Olomouc · Vseobecna fakultni nemocnice v Praze, Prague

  Registry updated 2026-10-28

• NCT05939414

  An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  University Hospital Olomouc, Olomouc · Fakultni Nemocnice Ostrava, Poruba · Fakultni Nemocnice V Motole, Prague 5

  Registry updated 2026-10-21

• NCT06136650

  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Masarykuv Onkologicky Ustav, Brno-Stred · University Hospital Olomouc, Olomouc · Fakultni Nemocnice Motol a Homolka, Prague · Vseobecna Fakultni Nemocnice V Praze, Prague 2

  Registry updated 2026-10-20

• NCT07028853

  This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  Trial Treatment · Phase 3 · Pfizer

  Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Masarykuv Onkologicky Ustav, Brno-Stred · Fakultni nemocnice Hradec Kralove, Hradec Králové · Nemocnice AGEL Nový Jičín a.s., Nový Jičín · University Hospital Olomouc, Olomouc · Urocentrum Praha s.r.o., Prague · Fakultni Nemocnice Motol a Homolka, Prague · Fakultni Thomayerova nemocnice, Prague

  Registry updated 2026-10-14

• NCT03520478

  A clinical study on SHR3680 combined with androgen deprived therapy (ADT) versus Bicalutamide combined with ADT in treatment of prostate cancer

  Trial Treatment · Phase 3 · Jiangsu Hengrui Pharmaceuticals Co. Ltd.

  Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · University Hospital Olomouc, Olomouc · Nemocnice Na Homolce, Prague 5

  Registry updated 2026-08-17

• NCT06981026

  The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy

  Trial Treatment · University Hospital Olomouc

  Urology clinic, University hospital Olomouc, Olomouc

  Registry updated 2026-07-27

• NCT05803941

  Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  University Hospital Olomouc, Olomouc · Fakultni Nemocnice V Motole, Prague 5

  Registry updated 2026-06-04

• NCT03819101

  Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

  Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris

  Fakultni Nemocnice Olomouc (Fnol) - Onkologicka Klinika, Olomouc

  Registry updated 2026-05-06

• NCT04916613

  ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

  Trial Treatment · Phase 3 · UNICANCER

  University Hospital Olomouc, Olomouc · Fakultni nemocnice Kralovske Vinohrady, Prague

  Registry updated 2026-04-28

• NCT05974774

  Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

  Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC

  Fakultni nemocnice Brno, Brno · University Hospital Olomouc, Olomouc

  Registry updated 2025-09-19

• NCT06665932

  Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins

  Trial Treatment · University Hospital Ostrava

  University Hospital Ostrava, Ostrava

  Registry updated 2024-11-12

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error